Flyte Aviation, Inc. — Form 8-K
Filed October 5, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 72/100
What the filing says
Effective October 5, 2026, Catheter Precision, Inc. changed its name to Flyte Aviation, Inc. and its NYSE American ticker symbol from VTAK to VJET. The company is repositioning as a technology-enabled private aviation business targeting the $11.6B US private jet charter market (projected 6.9% CAGR to $16B by 2031). David Jenkins is CEO; Marc Sellouk founded Flyte in 2018. The company plans Q4 2026 investments in website, mobile app, digital marketing, and customer acquisition, and has partnered with the Hamptons International Film Festival as 'Official Air Travel Partner.' Life Sciences operations (LockeT, VIVO products) will continue with committed funding.
Why this rating
Major repositioning from medical devices to aviation for $3.9M-cap company. Significant if executed, but unproven business model, limited operating history, and losses create execution risk.
Price action (we called it neutral)
at our read pending | +10 min pending | +30 min pending | +1 hr pending | +4 hrs pending |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from October 5, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.